United States Anesthesia Drugs Market Report 2017

October 2017 | 106 pages | ID: UBCDC8CBF04PEN
QYResearch

Abstracts

In this report, the United States Anesthesia Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Anesthesia Drugs in these regions, from 2012 to 2022 (forecast).

United States Anesthesia Drugs market competition by top manufacturers/players, with Anesthesia Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astrazeneca
• Fresenius-Kabi
• AbbVie
• Baxter Healthcare
• B.Braun
• Maruishi
• Piramal
• Troikaa
• Claris Life sciences
• Hikma Pharmaceuticals
• Mylan
• Nhwa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Propofol
• Etomidate
• Midazolam
• Sevoflurane
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anesthesia Drugs for each application, including

• Intravenous Anesthetics
• Inhalational Anesthetics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Anesthesia Drugs Market Report 2017

1 ANESTHESIA DRUGS OVERVIEW

1.1 Product Overview and Scope of Anesthesia Drugs
1.2 Classification of Anesthesia Drugs by Product Category
  1.2.1 United States Anesthesia Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Anesthesia Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Propofol
  1.2.4 Etomidate
  1.2.5 Midazolam
  1.2.6 Sevoflurane
  1.2.7 Other
1.3 United States Anesthesia Drugs Market by Application/End Users
  1.3.1 United States Anesthesia Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Intravenous Anesthetics
  1.3.3 Inhalational Anesthetics
1.4 United States Anesthesia Drugs Market by Region
  1.4.1 United States Anesthesia Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Anesthesia Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Anesthesia Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Anesthesia Drugs Status and Prospect (2012-2022)
  1.4.5 New England Anesthesia Drugs Status and Prospect (2012-2022)
  1.4.6 The South Anesthesia Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Anesthesia Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anesthesia Drugs (2012-2022)
  1.5.1 United States Anesthesia Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Anesthesia Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANESTHESIA DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anesthesia Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anesthesia Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anesthesia Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Anesthesia Drugs Market Competitive Situation and Trends
  2.4.1 United States Anesthesia Drugs Market Concentration Rate
  2.4.2 United States Anesthesia Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anesthesia Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANESTHESIA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Anesthesia Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Anesthesia Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Anesthesia Drugs Price by Region (2012-2017)

4 UNITED STATES ANESTHESIA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Anesthesia Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anesthesia Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Anesthesia Drugs Price by Type (2012-2017)
4.4 United States Anesthesia Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANESTHESIA DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Anesthesia Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Anesthesia Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANESTHESIA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Astrazeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anesthesia Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astrazeneca Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Fresenius-Kabi
  6.2.2 Anesthesia Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Fresenius-Kabi Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 AbbVie
  6.3.2 Anesthesia Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AbbVie Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Baxter Healthcare
  6.4.2 Anesthesia Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Baxter Healthcare Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 B.Braun
  6.5.2 Anesthesia Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 B.Braun Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Maruishi
  6.6.2 Anesthesia Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Maruishi Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Piramal
  6.7.2 Anesthesia Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Piramal Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Troikaa
  6.8.2 Anesthesia Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Troikaa Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Claris Life sciences
  6.9.2 Anesthesia Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Claris Life sciences Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Hikma Pharmaceuticals
  6.10.2 Anesthesia Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hikma Pharmaceuticals Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Mylan
6.12 Nhwa

7 ANESTHESIA DRUGS MANUFACTURING COST ANALYSIS

7.1 Anesthesia Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anesthesia Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anesthesia Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anesthesia Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANESTHESIA DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Anesthesia Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anesthesia Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Anesthesia Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Anesthesia Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anesthesia Drugs
Figure United States Anesthesia Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Anesthesia Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Propofol Product Picture
Figure Etomidate Product Picture
Figure Midazolam Product Picture
Figure Sevoflurane Product Picture
Figure Other Product Picture
Figure United States Anesthesia Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Anesthesia Drugs by Application in 2016
Figure Intravenous Anesthetics Examples
Table Key Downstream Customer in Intravenous Anesthetics
Figure Inhalational Anesthetics Examples
Table Key Downstream Customer in Inhalational Anesthetics
Figure United States Anesthesia Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anesthesia Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Anesthesia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anesthesia Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Anesthesia Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Anesthesia Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anesthesia Drugs Sales Share by Players/Suppliers
Figure 2017 United States Anesthesia Drugs Sales Share by Players/Suppliers
Figure United States Anesthesia Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anesthesia Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anesthesia Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anesthesia Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Anesthesia Drugs Revenue Share by Players/Suppliers
Table United States Market Anesthesia Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Anesthesia Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Anesthesia Drugs Market Share of Top 3 Players/Suppliers
Figure United States Anesthesia Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anesthesia Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anesthesia Drugs Product Category
Table United States Anesthesia Drugs Sales (K Units) by Region (2012-2017)
Table United States Anesthesia Drugs Sales Share by Region (2012-2017)
Figure United States Anesthesia Drugs Sales Share by Region (2012-2017)
Figure United States Anesthesia Drugs Sales Market Share by Region in 2016
Table United States Anesthesia Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anesthesia Drugs Revenue Share by Region (2012-2017)
Figure United States Anesthesia Drugs Revenue Market Share by Region (2012-2017)
Figure United States Anesthesia Drugs Revenue Market Share by Region in 2016
Table United States Anesthesia Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Anesthesia Drugs Sales (K Units) by Type (2012-2017)
Table United States Anesthesia Drugs Sales Share by Type (2012-2017)
Figure United States Anesthesia Drugs Sales Share by Type (2012-2017)
Figure United States Anesthesia Drugs Sales Market Share by Type in 2016
Table United States Anesthesia Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anesthesia Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anesthesia Drugs by Type (2012-2017)
Figure Revenue Market Share of Anesthesia Drugs by Type in 2016
Table United States Anesthesia Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Anesthesia Drugs Sales Growth Rate by Type (2012-2017)
Table United States Anesthesia Drugs Sales (K Units) by Application (2012-2017)
Table United States Anesthesia Drugs Sales Market Share by Application (2012-2017)
Figure United States Anesthesia Drugs Sales Market Share by Application (2012-2017)
Figure United States Anesthesia Drugs Sales Market Share by Application in 2016
Table United States Anesthesia Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Anesthesia Drugs Sales Growth Rate by Application (2012-2017)
Table Astrazeneca Basic Information List
Table Astrazeneca Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astrazeneca Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure Astrazeneca Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure Astrazeneca Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table Fresenius-Kabi Basic Information List
Table Fresenius-Kabi Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fresenius-Kabi Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure Fresenius-Kabi Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure Fresenius-Kabi Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure AbbVie Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure AbbVie Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table Baxter Healthcare Basic Information List
Table Baxter Healthcare Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter Healthcare Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure Baxter Healthcare Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure Baxter Healthcare Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table B.Braun Basic Information List
Table B.Braun Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure B.Braun Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure B.Braun Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure B.Braun Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table Maruishi Basic Information List
Table Maruishi Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Maruishi Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure Maruishi Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure Maruishi Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table Piramal Basic Information List
Table Piramal Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Piramal Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure Piramal Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure Piramal Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table Troikaa Basic Information List
Table Troikaa Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Troikaa Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure Troikaa Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure Troikaa Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table Claris Life sciences Basic Information List
Table Claris Life sciences Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Claris Life sciences Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure Claris Life sciences Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure Claris Life sciences Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table Hikma Pharmaceuticals Basic Information List
Table Hikma Pharmaceuticals Anesthesia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hikma Pharmaceuticals Anesthesia Drugs Sales Growth Rate (2012-2017)
Figure Hikma Pharmaceuticals Anesthesia Drugs Sales Market Share in United States (2012-2017)
Figure Hikma Pharmaceuticals Anesthesia Drugs Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Nhwa Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anesthesia Drugs
Figure Manufacturing Process Analysis of Anesthesia Drugs
Figure Anesthesia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anesthesia Drugs Major Players/Suppliers in 2016
Table Major Buyers of Anesthesia Drugs
Table Distributors/Traders List
Figure United States Anesthesia Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Anesthesia Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anesthesia Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Anesthesia Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Anesthesia Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Anesthesia Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Anesthesia Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Anesthesia Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Anesthesia Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Anesthesia Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Anesthesia Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anesthesia Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anesthesia Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources